Tokai Pharmaceuticals Appoints John McBride As Chief Operating Officer
2/11/2014 8:11:24 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, today announced the appointment of John McBride as chief operating officer. Mr. McBride brings nearly 30 years of biotech and pharmaceutical experience to Tokai, and he will have broad responsibility for business development and operational functions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by